Cite
MLA Citation
Max S. Mano. “Pathologic response at the epicenter of the treatment decision-making process in Human Epidermal Receptor–Type 2 overexpressing (Her2+) Early Breast Cancer (EBC): Challenges and opportunities for financially-constrained healthcare systems.” Breast, vol. 54, 2020, pp. 331–334. http://access.bl.uk/ark:/81055/vdc_100117935480.0x00003c